INTENDED FOR UK & IRELAND HEALTHCARE PROFESSIONALS

INTENDED FOR UK & IRELAND HEALTHCARE PROFESSIONALS

PRESCRIBING INFORMATION

The Chiesi CF Portfolio

Living and breathing cystic fibrosis

https://chiesicysticfibrosis.co.uk/wp-content/uploads/2018/08/Quinsar-logo-50mm-with-2mm-generic-and-5mm-BT_small.jpg

Quinsair® (levofloxacin hemihydrate) is the first inhaled quinolone for the management of chronic pulmonary infections due to Pseudomonas aeruginosa in adult patients with cystic fibrosis.1

https://chiesicysticfibrosis.co.uk/wp-content/uploads/2018/08/Bramitob-CMYK-Complete-Bold-376-50mm_small.png

Bramitob® (tobramycin) is for the management of chronic pulmonary infection due to Pseudomonas aeruginosa in patients with cystic fibrosis aged 6 years and older.2

https://chiesicysticfibrosis.co.uk/wp-content/uploads/2018/08/logo_bronchitol_home-1.png

Bronchitol® (mannitol) is for the treatment of cystic fibrosis in adults, as an add-on therapy to best standard of care.3

  1. Quinsair® Summary of Product Characteristics. Available online at https://www.medicines.org.uk/emc/medicine/32009. Accessed March 2018.
  2. Bramitob® Summary of Product Characteristics. Available online at https://www.medicines.org.uk/emc/medicine/21427. Accessed March 2018.
  3. Bronchitol® Summary of Product Characteristics. Available online at https://www.medicines.org.uk/emc/medicine/26446. Accessed March 2018.